Promoxil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Promoxil

Property Description
Active Ingredient Amoxicillin
Form Oral Solid (Tablet/Capsule) or Oral Suspension
Pharmacological Class β-lactam antibiotic (Aminopenicillin)
General Purpose Systemic Antimicrobial Therapy (Bactericidal)
Origin Semi-synthetic

What Type of Medicine is Promoxil?

Promoxil is a prescription-only medication whose defining active ingredient is the compound Amoxicillin, classifying it as a broad-spectrum antibiotic. It belongs to the β-lactam antibiotic class, which is an established, widely utilized category of antimicrobial agents. It is recognized as a first-line option for various common bacterial infections.

More specifically, Promoxil is identified as an aminopenicillin, a semi-synthetic group chemically derived from the natural penicillin nucleus. Amoxicillin is classified as an essential medicine for its established safety profile and broad utility in global healthcare. This classification confirms its therapeutic scope is strictly limited to addressing illnesses caused by bacteria.

Composition and Physical Form of Promoxil

Promoxil is typically manufactured as a single-ingredient product, focusing entirely on the antibacterial efficacy of its active ingredient, Amoxicillin. It is prepared for the oral route of administration in common dosage forms such as tablets or capsules, or as a dry powder that is mixed with an aqueous base to create a liquid oral suspension. The liquid form is often specifically positioned for the pediatric patient group due to ease of swallowing.

Aside from the active compound, the drug requires a base of inert excipients—non-active materials—for stability and shape. Amoxicillin is characterized by its efficacy and stability primarily through the oral route, making it effective for systemic antimicrobial therapy.

What is the General Purpose of Promoxil?

The general purpose of Promoxil is to provide systemic antimicrobial therapy by functioning as a bactericidal agent. This means its primary therapeutic role is to actively kill the disease-causing bacteria that may be present throughout the body, rather than merely inhibiting their growth. The underlying function is achieved through a disruption of bacterial cell wall synthesis, a biological action that leads to the destruction of susceptible microorganisms.

Regulatory References

  1. Essential Medicines List (WHO)

What side effects are possible with Promoxil?

Possible Side Effects and Safety Information

Promoxil (Amoxicillin) has an officially documented safety profile, with potential adverse reactions classified by government regulatory authorities based on frequency and affected body system.


Adverse Reaction Classifications

Adverse reactions are grouped by System-Organ Class (SOC) in official labeling, including: Gastrointestinal Disorders (Diarrhea, Nausea, Vomiting), Skin and Subcutaneous Tissue Disorders (Rash, Urticaria), Blood and Lymphatic System Disorders, and Immune System Disorders.

Frequency Classification Documented Examples
Common Diarrhea, Nausea, Skin rash
Uncommon Vomiting, Urticaria, Pruritus
Rare / Very Rare Severe skin reactions, Hepatitis, Cholestatic jaundice, Convulsions, Anaphylactic reaction

Regulatory Safety Notes

Serious adverse reactions documented in regulatory sources include Anaphylactic Reactions, Severe Cutaneous Adverse Reactions (such as Stevens-Johnson syndrome, SJS), and Pseudomembranous Colitis (Clostridioides difficile-associated diarrhea).

Safety restrictions formally prohibit use in individuals with a known history of hypersensitivity to any penicillin or other beta-lactam agents, due to the documented risk of severe allergic response.

Population-specific safety considerations are noted for certain groups. For patients with severe renal impairment, an official dosage adjustment is recommended to manage the drug's slower elimination. Furthermore, its use is formally restricted in individuals with infectious mononucleosis due to a high documented incidence of rash. The official label also notes that high concentrations in urine may cause false-positive results in specific non-enzymatic urinary glucose tests.

Overdose and Emergency Response

Overdose Manifestations and When to Seek Help

Overdosage with Promoxil (Amoxicillin) is officially documented to present primarily with gastrointestinal distress. The most common manifestations listed in regulatory sources include nausea, vomiting, and diarrhea.

The official prescribing information highlights the potential for severe systemic outcomes:

  • Renal Risk: The formation of amoxicillin crystalluria (drug crystals in the urine) is a recognized finding that may progress to acute oliguric renal failure.
  • Neurological Risk: Central nervous system effects, such as convulsions or seizures, have been reported in cases of significant overexposure.

Mandated Emergency Action and Supportive Care

Regulatory guidance mandates that the medication be discontinued immediately upon suspicion of overdose. Emergency medical attention must be sought immediately. If severe manifestations such as a seizure or trouble breathing occur, emergency services must be called without delay. No specific antidote is known, and management focuses on symptomatic and supportive measures.

Listed procedures include maintaining adequate fluid intake and promoting diuresis to mitigate the risk of crystalluria. Hemodialysis is documented as a procedural option for drug removal in severe cases. Patients with pre-existing impaired renal function are officially noted to be at a higher risk of toxicity due to decreased drug clearance.

Therapeutic Uses of Promoxil

What Promoxil Treats: Main Uses and Benefits

Promoxil (Amoxicillin) is commonly used to provide systemic antimicrobial therapy for various conditions. It is applied in addressing bacterial infections and is relevant for easing patient discomfort. This medication is used across multiple therapeutic domains, appearing in clinical settings marked by the heightened expression of symptoms that interfere with daily stability.

The medicine is used for managing acute, symptom-driven conditions like streptococcal pharyngitis, tonsillitis, acute otitis media (middle ear infection), acute bacterial sinusitis, uncomplicated Urinary Tract Infections (UTIs), bacterial skin and soft tissue infections, and odontogenic infections (dental abscesses). It is relevant when symptoms cluster into patterns of fever, sore throat, ear pain, or facial pressure, providing support that helps ease the overall symptom burden.

“Promoxil plays a role in managing the bacterial cause to help ease the overall symptom burden.”

This specialized application may contribute to comfort in scenarios requiring targeted assistance, such as part of the multi-drug regimen to eliminate H. pylori associated with peptic ulcers, or as a prophylactic measure before specific procedures in high-risk patients.


Quick Fact: Support for Acute Systemic Symptoms Promoxil is commonly used when symptoms related to systemic imbalance, such as fever and malaise, accompany localized pain, and it supports general well-being during periods of heightened symptoms.

Eligibility and Restrictions for Use

Who can and cannot use Promoxil?

The population eligibility for Promoxil (Amoxicillin) is strictly defined by regulatory documents based on a patient's hypersensitivity status, age, and organ function.

Eligibility Entity Map
Absolute Contraindications History of hypersensitivity to Amoxicillin, any penicillin, or any severe immediate reaction to other beta-lactam antibiotics (e.g., cephalosporins).
Conditional Restrictions Patients with severe renal impairment (GFR < 30 mL/min) must receive dose reduction; the 875 mg dose is prohibited.
Use is not recommended in patients with infectious mononucleosis (glandular fever) due to a high risk of developing a generalized rash.
Age-Group Eligibility Use is established for adults and pediatric patients (children 3 months). Infants leq 3 months have a restricted maximum daily dose.
Pregnancy/Lactation Status Use is generally considered acceptable during both pregnancy and breastfeeding when clearly needed, as the drug is classified as low-risk and transfers in only small amounts to milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products — official regulatory information for Promoxil

The official regulatory profile for Promoxil identifies specific interactions based on effects on drug elimination, exposure, and pharmacodynamic outcomes, as documented by governmental authorities.

Interacting Substance Official Description of Interaction Mechanism/Type
Probenecid Results in increased and prolonged blood levels of amoxicillin. Decreases renal tubular secretion
Oral Anticoagulants May increase the prolongation of prothrombin time (INR). Pharmacodynamic effect on coagulation
Allopurinol Increases the incidence of rash. Pharmacodynamic effect
Oral Contraceptives May lead to lower estrogen reabsorption and reduced efficacy. Alteration of gastrointestinal flora
Bacteriostatic Antibacterials May interfere with the bactericidal effects of penicillin. Pharmacodynamic antagonism

Interaction-Context Constraints

The official labeling does not classify any combination as formally contraindicated, and no mandatory separation windows for dose timing are cited for Promoxil. However, a procedural constraint is noted for laboratory testing: high concentrations of the drug in urine may result in false-positive reactions when testing for glucose using non-enzymatic methods, such as CLINITEST®, Benedict's Solution, or Fehling's Solution. The documented interactions require recognition of the potential for altered drug exposure (e.g., with Probenecid) or increased risk of specific events (e.g., rash with Allopurinol) as stated in the prescribing information.

Mechanism of Action

How Promoxil Works

Promoxil's action is defined as bactericidal, meaning it actively destroys susceptible bacteria. Its mechanism is highly specific and involves disrupting the molecular architecture of the pathogen.


Targeted Inhibition of Bacterial Cell Wall Synthesis

Promoxil's defining mechanism involves the irreversible inhibition of specific bacterial enzymes known as Penicillin-Binding Proteins (PBPs). These enzymes, which reside on the bacterial cell membrane, are critical transpeptidases responsible for the final cross-linking of peptidoglycan strands. By covalently binding to and deactivating these PBPs, the drug effectively blocks the construction of the bacterial cell wall, which is a structure entirely absent in human cells.


Cascade Leading to Cell Lysis

The failure to synthesize a rigid, intact cell wall causes the bacteria to become highly susceptible to their own internal osmotic pressure. This structural breakdown, often amplified by the activation of the bacteria's own latent autolytic enzymes, results in a rapid and catastrophic loss of membrane integrity. The resulting physiological consequence is cell lysis (rupture) and immediate death.


Mechanism Constraints: Resistance

The drug’s mechanism is constrained by acquired bacterial resistance, primarily through the production of β-lactamase enzymes. These enzymes chemically cleave and deactivate the core β-lactam structure of Promoxil before it can reach and inhibit the PBP targets. This enzymatic breakdown directly overrides the destructive cascade, thus preventing the intended inhibitory action.

Dosage and Administration Information

Promoxil (Amoxicillin) is typically administered via the oral route using capsules, tablets, or a reconstituted suspension. Parenteral administration through intravenous (IV) or intramuscular (IM) routes is also indicated, primarily for patients who are unable to tolerate oral intake. The standard usage pattern relies on a precise frequency: immediate-release formulations are generally prescribed to be taken in divided doses either every 8 hours (q8h) or every 12 hours (q12h). The total dose for adults commonly ranges from 250 mg to 875 mg per administration, with the absolute maximum daily dose restricted to 6 grams in divided doses.

Administration must strictly comply with specific conditions based on the formulation used. Immediate-release forms may be taken with or without food as absorption is not significantly altered. However, the Extended-Release (ER) 775 mg tablet must be ingested within one hour of finishing a meal. Furthermore, all ER tablets must be swallowed whole and must not be crushed or chewed. When using the oral suspension, the powder requires reconstitution with water and must be shaken vigorously before the dose is accurately measured using a properly marked device.

Dosage adjustments are established for specific patient populations. Pediatric dosing must be calculated strictly by weight (e.g., in mg/kg/day), while dose modification is mandatory for adults with renal impairment. For severe reduction in kidney function, the maximum dose must be restricted to 500 mg every 24 hours. The duration of therapy is typically set for 10 to 14 days, with some specific bacterial infections requiring a minimum duration of 10 days.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Promoxil

The evidence for Promoxil (Amoxicillin) was built on a long history of use and structured clinical evaluations, including Randomized Controlled Trials (RCTs) and scientific reviews accepted by major health regulators. Research describes the patterns observed when the compound was studied for common bacterial infections. This overview focuses only on the structure and scope of the available research, not on individual treatment decisions or safety information.


Evidence for Use in Acute Respiratory and ENT Infections

Research has explored Promoxil for conditions characterized by episodic or acute changes, such as acute otitis media (middle ear infection) and streptococcal pharyngitis (strep throat). Studies used in the research exploring how symptoms change over time have included short-term RCTs that monitored outcomes compared to a placebo or another established treatment. Primary outcomes measured related to physical discomfort, such as the complete resolution of specific symptoms like ear pain or fever, and the rate of treatment failure. The populations observed in these trials included children, adolescents, and adults.


Evidence for Use in Systemic Infections

Research has also examined Promoxil for systemic infections, including uncomplicated Urinary Tract Infections (UTIs). Studies in these areas included evaluations of how the drug performed against the specific bacteria causing the infection. Research provided insight into short-term changes by measuring the microbiological eradication of the pathogen and the change in clinical status of the symptoms reflecting daily functioning or activity level.


Evidence in Specific Patient Populations

Specialized pharmacokinetic (PK) research was conducted to support a foundational understanding of the compound's behavior in specific cohorts, including pregnant women. While children and adolescents have been included in efficacy trials, variability in evidence quality was observed across studies, and data for certain groups remain limited, such as individuals with specific comorbidities.


Documented Research Gaps and Uncertainties

Scientific reviews and regulatory documentation consistently highlight several limitations. Many comparative trials are structured as non-inferiority studies, which examine whether the medicine is not worse than a comparator. Research also describes heterogeneity, where findings were mixed or inconsistent across different study locations. Data for certain groups remain limited, and comparative data against some newer-generation antibiotics is not comprehensive.

Key Studies & References

  1. Amoxicillin (National Library of Medicine, Drug Information)
  2. Amoxicillin and Clarithromycin and Lansoprazole Capsules (MedlinePlus Drug Information, H. pylori regimen)
  3. Amoxicillin: LiverTox Clinical and Research Information (Special Population Data Context)

Frequently Asked Questions (FAQ)

Common questions about Promoxil (FAQ)


Q: What foods or drinks should be avoided while taking Promoxil?

Official labeling confirms that the immediate-release form of Promoxil may be taken with or without food, as absorption is generally unaffected.

However, the extended-release tablet has a specific condition and must be ingested within one hour of finishing a meal. Regulatory documents do not typically list other specific foods or drinks that must be strictly avoided with this medication.


Q: Do I need to take Promoxil at the same time every day?

Promoxil is prescribed in regular, divided doses, such as every 8 or 12 hours, to maintain a steady, effective concentration of the medicine in the body.

Taking the medication at consistent times helps ensure that this steady level is maintained throughout the course of treatment, which is important for fighting bacterial infection.


Q: Can Promoxil be cut in half, or must it be swallowed whole?

Extended-release Promoxil tablets is required by regulatory guidance to be swallowed whole and should not be cut, crushed, or chewed.

For other oral forms, such as immediate-release capsules or tablets, official instructions recommend following the specific directions provided for that particular product type.


Q: Is Promoxil used for more than one condition?

Yes, Promoxil is approved and indicated for the treatment of various bacterial infections in several areas of the body.

According to official labeling, this includes infections of the ear, nose, throat, skin, lower respiratory tract, and the genitourinary tract, as well as use in combination therapy for H. pylori infection.


Q: Are there any official registry studies or post-marketing data available for Promoxil?

Regulatory bodies require that adverse reactions occurring after a product is launched (post-marketing) are continuously collected and reported.

This process confirms that the safety profile of the drug is under ongoing observation, contributing to the comprehensive understanding of the medication.


Q: Does Promoxil contain any ingredients known to cause allergic reactions?

The active ingredient in Promoxil is Amoxicillin, which belongs to the penicillin class of antibiotics.

Due to the documented risk of severe allergic responses, the regulatory label states that use is contraindicated (prohibited) in patients who have a known history of hypersensitivity to any penicillin or other related beta-lactam agents.


Q: What is the general regulatory status of Promoxil globally?

The active ingredient in Promoxil, Amoxicillin, holds a prominent international regulatory status.

It is explicitly recognized on the World Health Organization’s (WHO) Essential Medicines List, confirming its established safety profile and broad utility in global healthcare systems.


Q: What happens if I forget to take Promoxil?

Missing a dose may reduce the overall effectiveness of the treatment by potentially disrupting the steady medication levels needed to fight the infection.

Official guidance emphasizes that patients should continue with the regular schedule and should not take a double dose to compensate for a forgotten one.


Q: Can Promoxil be used long-term?

Official documentation reflects that treatment durations are typically short (e.g., 10 to 14 days), rather than indefinite long-term use.

Regulatory warnings state that prolonged use of an anti-infective may occasionally lead to the overgrowth of non-susceptible organisms (bacteria or fungi).


Q: Is it true that Promoxil can affect sleep?

Official product information confirms that certain side effects affecting the Central Nervous System (CNS) have been reported with this class of medication.

These reported effects can include symptoms such as insomnia (difficulty sleeping), hyperactivity, or anxiety.


Q: Can Promoxil be taken with a common multivitamin?

While interactions between penicillins and vitamins or minerals are generally rare compared to some other antibiotic classes, potential interference is a possibility.

For patients taking any multivitamin or supplement, consulting a healthcare provider is generally recommended to determine if dose timing should be adjusted.


Q: Is a metallic taste a known side effect of Promoxil?

Changes in taste perception, medically known as dysgeusia, have been reported in some patients taking the medication.

This category of side effects covers various changes in how a person tastes, which may include a metallic taste.


Q: Is there a generic version of Promoxil available?

Yes, the active ingredient contained within Promoxil is Amoxicillin, which is widely recognized and available.

Amoxicillin is commonly manufactured and distributed as a generic medication across numerous countries.


Q: Are there specific tests required before starting Promoxil?

Official regulatory documentation emphasizes the importance of a careful inquiry before starting treatment.

Regulatory documents indicate that the prescribing healthcare provider should conduct a careful inquiry regarding any previous allergic reactions or hypersensitivity history concerning penicillins, cephalosporins, or other beta-lactam agents.


Q: Is Promoxil known to affect mood or energy levels?

Central Nervous System (CNS) effects have been reported in the official safety profile, although rarely.

These documented effects include symptoms such as agitation, confusion, and behavioral changes, which could potentially affect a person's mood or energy levels.


Q: Does taking Promoxil require any lifestyle changes?

Official labeling primarily emphasizes strict adherence to the prescribed dosing schedule and completion of the full course of therapy.

The key required change is the specific administration condition: the extended-release form must be taken within one hour of finishing a meal.


Q: If I experience a mild headache, is that normal while taking Promoxil?

Headache is a side effect that has been reported in post-marketing data for the medication.

If any symptom, including a headache, is concerning or persists, consulting a healthcare provider is advised.


Q: Can Promoxil be used by people with a history of liver issues?

Official warnings state that caution is required in people who have a history of liver disease or impaired hepatic function.

Regulatory documents indicate that the medicine may potentially worsen these conditions, and a history of cholestatic jaundice is typically a restriction for use.


Q: Does Promoxil interact with alcohol consumption?

Official labeling does not typically list a direct chemical interaction between Promoxil and alcohol.

However, alcohol consumption may worsen some of the drug’s common side effects, such as gastrointestinal upset, and can hinder the body's natural healing process from the underlying infection.


Q: Is it okay to drive or operate machinery while taking Promoxil?

Regulatory documents generally state that the medication does not cause issues with driving or operating machinery for most individuals.

Nevertheless, patients should be aware of rare potential side effects, such as dizziness or confusion, that could temporarily affect their ability.


Q: What should I do if the expected effects of Promoxil don't seem to happen?

If symptoms of the infection do not begin to improve after a few days of treatment, or if the patient develops new or worsening symptoms, official patient information advises consulting a healthcare professional for re-evaluation of the treatment plan.


Q: Are there any known interactions between Promoxil and herbal supplements?

Interactions with herbal supplements are generally not detailed in the official regulatory documents, which primarily focus on drug-drug interactions.

For this reason, it is generally recommended that patients inform their healthcare provider of all products, including supplements and herbal remedies, that they are taking.


Q: How does the official documentation describe the long-term safety profile of Promoxil?

The active ingredient in Promoxil has a long history of use, confirmed by extensive clinical documentation since the 1970s.

This long experience supports a well-documented safety profile, with all known adverse reactions categorized by their frequency in regulatory documents.


Q: Does the efficacy of Promoxil change over time?

Regulatory agencies emphasize using the medication only when a bacterial infection is proven or strongly suspected.

This careful use is stressed to reduce the risk of developing drug-resistant bacteria, which could compromise the drug’s intended effectiveness over time.


Q: Can the cost of Promoxil be covered by insurance?

The generic version of Promoxil, Amoxicillin, is widely recognized by healthcare payors.

The cost is typically covered by most insurance plans, including commercial insurance and government programs, although the exact coverage details depend on the specific plan.


Q: How quickly do the side effects of Promoxil typically appear and disappear?

Most reported side effects are temporary and typically resolve shortly after the medication course is completed.

However, official safety notes warn that some serious adverse reactions, such as Clostridioides difficile-associated diarrhea, may occur even during or after the end of treatment.


Q: Is it necessary to finish the entire course of Promoxil as prescribed?

Yes, it is generally recommended to finish the entire prescribed course, even if symptoms begin to improve quickly.

This practice is essential to ensure complete eradication of the infection and helps to reduce the risk of developing drug-resistant bacteria.


Q: Does Promoxil affect fertility or hormone levels?

Official regulatory information states that Promoxil is generally considered acceptable for use during pregnancy and breastfeeding.

However, the product label also indicates that it may reduce the effectiveness of combined oral contraceptives.

How should Promoxil be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory guidelines define specific conditions for storing and disposing of Promoxil to maintain its stability.

Condition Type Requirement
Unopened Product No special storage temperature precautions are required.
Reconstituted Solution Must be stored refrigerated (between 2 C and 8 C).
In-Use Stability The refrigerated, reconstituted solution must be discarded after 24 hours.
Handling Gentle swirling is required during preparation to avoid frothing. Administration should occur in a well-ventilated area.
Disposal Any unused solution remaining in the device after treatment must be discarded. Disposal of all waste material must follow local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Promoxil found in:

A-Z Index: